📊 Analyst Consensus & Targets
- Analyst Rating: None
- Price Target: $12.44444
- Sector: Healthcare – Drug Manufacturers – Specialty & Generic
💡 The Growth Thesis
None Consensus: Viatris Inc. Analysts project a -0.0% potential upside. Currently trading at a Forward P/E of 5.055488.